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A high intake of saturated fat and cholesterol and a low intake of polyunsaturated fatty acids have been related to an 
increased risk of cardiovascular disease. Cardiovascular disease has been associated with dementia. We investigated the 
association between fat intake and incident dementia among participants, age 55 years or older, from the population- 
based prospective Rotterdam Study. Food intake of 5,386 nondemented participants was assessed at baseline with a 
semiquantitative food-frequency questionnaire. At baseline and after an average of 2.1 years of follow-up, we screened for 
dementia with a three-step protocol that included a clinical examination. The risk of dementia at follow-up (RR [95% 
CI]) was assessed with logistic regression. After adjustment for age, sex, education, and energy intake, high intakes of the 
following nutrients were associated with an increased risk of dementia: total fat (RR = 2.4 [1.1-5.2]), saturated fat 
(RR = 1.9 [0.9-4.0]), and cholesterol (RR = 1.7 [0.9-3.21). Dementia with a vascular component was most strongly 
related to total fat and saturated fat. Fish consumption, an important source of n-3 polyunsaturated fatty acids, was 
inversely related to incident dementia (RR = 0.4 [0.2-0.9]), and in particular to Alzheimer's disease (RR = 0.3 [0.1- 
0.91). This study suggests that a high saturated fat and cholesterol intake increases the risk of dementia, whereas fish 
consumption may decrease this risk. 
Kalmijn S, Launer LJ, Ott A, Witteman JCM, Hofman A, Breteler MMB. Dietary fat intake and the risk of 
incident dementia in the Rotterdam study. Ann Neurol 1997;42:776-782 
As the population includes a growing proportion of 
older people, dementia will become an increasing bur- 
den to society and the individual. Therefore, research 
on potentially modifiable risk factors, such as diet, is of 
enormous relevance. Few studies have reported on the 
relation between diet and dementia [1-31. Because the 
study designs were cross-sectional and the demented 
subjects were usually nursing-home residents, it was 
difficult to ascertain whether their diet was the cause or 
consequence of dementia. 
In this study, we focused on different components of 
fat intake, including total fat, saturated fat, cholesterol, 
and polyunsaturated fatty acids (PUFAs). Saturated fat 
and cholesterol may increase the risk of dementia, be- 
cause they are associated with adverse cardiovascular 
events [4-61. These events, in turn, have been related 
to both vascular dementia and Alzheimer's disease 
[7-10]. O n  the other hand, n-3 PUFAs, which have 
antithrombotic effects [ I  11, and n-6 PUFAs, which 
have a beneficial effect on the lipid profile [12, 131, 
may reduce the risk of dementia. We examined the as- 
sociation between fat intake and (subtypes of) demen- 
tia in a prospective population-based study, in which 
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dietary data were collected at baseline before the onset 
of dementia. 
Subjects and Methods 
Study Population 
We used data from the Rotterdam Study, which is a single- 
center prospective population-based study, designed to inves- 
tigate determinants of selected chronic diseases and disabili- 
ties in older persons [14). The conduct of the study was 
approved by the Medical Ethics Committee of the Erasmus 
University and written consent was obtained from all partic- 
ipants. All residents of a suburb in Rotterdam, age 55 years 
and older, were invited and of the 10,275 eligible subjects, 
7,983 (78%) agreed to participate. During a home visit, 
trained interviewers administered a questionnaire, covering, 
among other areas, sociodemographic background, medical 
history, and medication use. This was followed by two clin- 
ical examinations at the research center. Subjects living in 
nursing homes were visited at home. The food-frequency 
questionnaire was included in the baseline examinations after 
the pilot phase, and offered to independently living subjects, 
who underwent additional clinical examinations (n = 
6,250). As part of the protocol, subjects who scored below 
80 points on the cognitive portion of the Cambridge Mental 
Received May 14, 1997, and in revised form JuI 25. Accepted for 
publication JuI 30, 1997. 
Address correspondence to Dr Kalmijn, Department of Epidemiol- 
ogy and Biostatistics, Erasmus University Rotterdam, PO Box 1738, 
3000 D R  Rotterdam, The Netherlands. 
776 Copyright 0 1997 by the American Neurological Association 
Disorders of the Elderly Examination (CAMDEX) [ 151 (n = 
122), which is the neuropsychological test administered in 
the case-finding procedure for dementia, were excluded be- 
cause they were thought to be unable to provide reliable an- 
swers regarding their food patterns. Furthermore, 482 un- 
selected subjects did not receive a dietary questionnaire due 
to logistic reasons, and 212 respondents were excluded from 
the sample becaus f logical inconsistencies in the dietary 
interviews, resultin 2 in 5,434 completed questionnaires. 
Baseline data were collected from May 1990 to June 1993. 
Follow-up data were obtained until December 1994. Inci- 
dent dementia was ascertained in two ways, ie, on the basis 
of a study examination in those attending the follow-up visit, 
or from medical records if the subject refused reexamination 
or had died before reexamination. 
Dietary Intake 
Dietary intake was assessed with a 170-item semiquantitative 
food-frequency questionnaire, which is a modified version of 
a reliable and valid questionnaire [16, 171. Modifications of 
the original questionnaire included a different mode of ad- 
ministration and the addition of more detailed questions on 
vegetable, fruit, and meat consumption. The questionnaire 
was administered in two stages. In the first stage, respondents 
were asked to report foods consumed regularly (at least twice 
a month) in the last year. This took place at home. The 
second stage was completed during the second visit to the 
research center. After a review of the checked food items, a 
trained dietician asked the respondent how much and how 
often each food item was consumed. The whole procedure 
was completed in 40 minutes. Average daily nutrient intake 
was calculated by multiplying the frequency and amount 
consumed for each food item by its nutrient content listed in 
an automated version of the Dutch Food Composition Table 
[ 181. We used linoleic acid intake as a marker of n-6 PUFA 
intake, because it is the most important n-6 PUFA in West- 
ern populations (131. The intake of the 11-3 PUFAs eicosa- 
pentaenoic acid and docosahexaenoic acid was estimated by 
fish consumption, because fish is their main source. 
Dementia Case Finding 
Case-finding procedures for dementia have been described 
elsewhere [ 191. As in the baseline examination, the follow-up 
study examination consisted of a three-stage procedure. First, 
all participants were screened with the 30-point Mini-Mental 
State Examination (MMSE) [20] and the short version of the 
Geriatric Mental State Schedule (GMS-A, organic level) 
[a l l .  Subjects with an MMSE score below 26, or a GMS 
score greater than 0 were considered screen positive. They 
were subsequently examined with the CAMDEX, which in- 
cluded an informant interview [ 151. Participants who were 
judged to be demented or suspected of dementia after the 
CAMDEX were examined by a neurologist and tested by a 
neuropsychologist; a part also underwent magnetic resonance 
imaging of the brain. Additional information for those who 
did not complete the diagnostic phase was obtained from the 
general practitioner, the regional institute for outpatient 
mental health care, and specialist medical files. Diagnosis of 
Alzheimer’s disease (AD) was based on National Institute 
of Neurological and Communicative Disorders and Stroke- 
Alzheimer’s Disease and Related Disorders Association 
(NINCDS-ADRDA) criteria [22]. Patients with this diagno- 
sis had a gradually progressive global decline of cognitive 
functions for which no medical cause was found. Dementia 
patients with a history of stroke, who otherwise fulfilled AD 
criteria, were subclassified as having AD with cerebrovascular 
disease. Vascular dementia was diagnosed in accordance with 
National Institute of Neurological Disorders and Stroke- 
and Association Internationale pour la Recherche et 
I’Enseignement en Neurosciences (NINDS-AIREN) criteria 
[23]. In these patients the onset of dementia was related to 
cerebrovascular disease. They generally had an acute onset of 
dementia symptoms with stepwise progression of the disease. 
Diagnostic and Statistical Manual o f  Mental Disorders, third 
edition, revised (DSM-111-R) criteria were used to classify 
other dementias 1241. 
Other Measurements 
The following variables were considered as possible con- 
founding variables: age, sex, total energy intake, cigarette 
smoking (current, former, or never), alcohol consumption 
(none, < I  drink [13.2 g], 1-2 drinks, or 2 3  drinks 
per day), fiber consumption, antioxidant intake, and level 
of education (completed primary education; lower voca- 
tional training or general education; intermediate vocational 
training or intermediate and higher general education; and 
higher vocational training, college, or university) (United 
Nations Educational, Scientific and Cultural Organization, 
UNESCO). 
A history of cardiovascular disease at baseline, indicators 
of atherosclerosis, and total and high-density lipoprotein 
cholesterol were considered as possible mediators of the as- 
sociation between dietary factors and dementia. Data on 
medical history were obtained at the home interview. A his- 
tory of myocardial infarction was considered present if the 
subject reported an event that was diagnosed by a physician 
and led to hospitalization. A history of stroke was considered 
present if a self-reported event was confirmed by either a 
detailed history, neuroimaging, or discharge reports collected 
from the general practitioner or neurologist [25]. The fol- 
lowing indicators of atherosclerosis were used: plaques in the 
carotid arteries, intima-media wall thickness of the carotid 
artery, and ankle-brachial index of systolic blood pressure. 
Measurement methods are extensively described elsewhere 
[26]. Wall thickness was measured in a relatively small but 
random subset of subjects (n = 1,935), and we restricted the 
analyses on atherosclerosis to this subset. 
Statistical Analysis 
Complete information on diet, incidence of dementia, and 
confounding factors was available for 5,386 respondents. 
Mean daily nutrient intake in incident demented and non- 
demented subjects, and the difference (95% confidence in- 
tervals [CIS]) between the two groups, was obtained from 
analysis of covariance, controlling for age. Because of the 
high correlation between fat and total energy intake, energy- 
adjusted fat and fish intakes were calculated with the residual 
method [27]. This method gives an estimation of the regres- 
sion coefficient, which is independent of total energy intake. 
Energy-adjusted intake of, for example, saturated fat was cal- 
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culated as the summation of the residuals from regressing 
saturated fat on total energy intake and a constant equal to 
the expected saturated fat intake at the level of the mean 
total energy intake. Energy-adjusted intakes of the nutrients 
of interest were grouped into tertiles, with the lowest tertile 
as the reference group. 
We used multiple logistic regression analysis to estimate 
the relative risks (RRs)  for the associations between fat in- 
take, fish consumption, and incident dementia. We included 
confounding variables in the model. The p value for linear 
trend was assessed by putting the categorical variable as a 
continuous variable in the model. We also investigated 
whether there was effect modification by sex or age by in- 
cluding the product terms of the nutrients with sex or age in 
the model. 
Results 
Baseline characteristics are given in Table 1. Fifty-eight 
(1.10/0) of the 5,386 subjects became demented during 
follow-up (mean, 2.1 years [SD = 0.81); 42 (72%) 
were classified as having AD (including 5 with AD and 
cerebrovascular disease), 7 (12%) as having vascular de- 
mentia, and 9 (16%) as having other types of demen- 
tia. Age-adjusted mean intake of total and saturated fat 
was higher, and fish consumption lower, in subjects 
with incident dementia (Table 2). 
Subjects in the highest tertiles of total fat, saturated 
fat, and cholesterol intake had an increased risk of de- 
mentia (RR = 2.4, 95% CI: 1.1-5.2; RR = 1.9, 95% 
CI: 0.9-4.0; and RR = 1.7, 95% CI: 0.9-3.2, respec- 
tively) (Table 3 ) .  High total and saturated fat intakes 
were most strongly associated with an increased risk of 
dementia with a vascular component (vascular demen- 
tia and AD with cerebrovascular disease). Fish con- 
sumption was associated with a reduced risk of demen- 
tia (RR = 0.4, 95% CI: 0.2-0.9) and especially of AD 
without cerebrovascular disease (Table 4) .  Linoleic acid 
was also associated with a lower risk of dementia, al- 
Table l. Baseline Characteristics of Participunts Who 
Completed the Food-Frequency Questionnaire (n = 5,386/: 
The Rotterdam Study 
Characteristics 
Mean age (yr) 
Sex (meniwomen) 
Primary education only 
Median baseline MMSE score (range) 
Mean alcohol consumption, 2 1 drinkiday 
Current smokersb 
Former smokersb 
History of stroke‘ 
History of myocardial infarctiond 
”Standard deviation in parentheses. 
bInformarion available for 5,377 subjects. 
‘Information available for 5,290 subjects. 
dInformarion available for 5,321 subjecrs. 
MMSE = Mini-Mental State Examinarion. 
67.7 (7.8)” 
2,20413,182 
1,871 (34.7%) 
28 (16-30) 
1,518 (28.2%) 
1,256 (23.4%) 
2,305 (42.9%) 
77 (1.8%) 
380 (7.1%) 
though not significantly (RR = 0.6, 95% CI: 0.3-1.2). 
These associations did not change after additional ad- 
justment for cigarette smoking, alcohol consumption, 
fiber consumption, antioxidant intake, or serum total 
and high-density lipoprotein cholesterol. Entering the 
indicators of atherosclerosis into the model did not 
change the associations, compared with the associations 
in the same subsample, but without atherosclerosis in 
the model (data not shown). Adjustment for stroke or 
myocardial infarction did not alter the results; neither 
did exclusion of subjects with a history of stroke or 
myocardial infarction or exclusion of subjects who were 
using a prescribed diet. 
Discussion 
This large follow-up study showed an association be- 
tween dietary factors and incidence of dementia. High 
intakes of total fat, saturated fat, and cholesterol were 
related to an increased risk of dementia, and total and 
saturated fat in particular to dementia with a vascular 
component. Fish consumption was associated with a 
reduced risk of dementia, and most strongly with AD. 
To our knowledge, this is the first prospective cohort 
study that investigated the association between fat in- 
take and incident dementia. 
Some methodological problems of this study must 
be discussed. Dietary data collected from subjects who 
are cognitively impaired may be less reliable, because 
they may underestimate or overestimate their dietary 
intake, leading to differential misclassification [28]. 
Subjects with dementia at follow-up may more often 
be cognitively impaired at baseline than those who 
were not demented at follow-up. It does not appear 
very likely, however, that they consistently overre- 
ported the consumption of foods with a high saturated 
fat and cholesterol content and underreported the 
consumption of fish. In addition, we attempted to re- 
duce systematic reporting error by a priori excluding 
nursing-home residents, individuals with low baseline 
scores on the CAMDEX, and questionnaires with log- 
ical inconsistencies. This exclusion, on the other hand, 
increases the possibility of response bias. The incidence 
of dementia is more likely to have been higher in those 
who did not complete the dietary questionnaire, but it 
is not very likely that they also had a lower fat intake 
and a higher fish consumption. Therefore, response 
bias is not a plausible explanation for these findings. 
Another methodological problem would occur when 
subjects with incident dementia altered their food pat- 
tern at baseline, because of behavioral changes in pre- 
clinical stages of dementia. In our sample, however, 
subjects with incident dementia performed relatively 
well at the baseline cognitive screening tests. Still, we 
cannot fully exclude the possibility that these subjects 
changed their food pattern toward a higher consump- 
tion of high-fat foods and a lower consumption of fish. 
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Table 2. Age-Adjusted Mean Daily Intake o f  Selected Nutrients and Fish According to Incidence of Dementia: 
The Rotterdam Study 
Dementia at Follow-Up 
Daily Intake No (n = 5,328) Yes (n = 58) Difference (95% CI) 
Total energy (kJ) 
Total fat (en%) 
Saturated fat (en%) 
Cholesterol (mglMJ) 
Linoleic acid (enyo) 
Fish (a) 
8,254 (28.8)” 
36.5 (0.08) 
14.4 (0.04) 
28.5 (0.10) 
5.7 (0.04) 
15.8 (0.26) 
8,763 (278.5) 
38.2 (0.82) 
15.5 (0.42) 
30.1 (0.99) 
5.3 (0.38) 
10.9 (2.48) 
509 (-40, 1,058) 
1.7 (0.1,3.3) 
1.1 (0.3, 1.9) 
1.6 (-0.53, 3.44) 
-0.4 (- 1.2, 0.3) 
-4.8 (-9.7,O.l) 
“Standard error in parentheses. 
CI = confidence interval; en% = intake as percentage of total energy intake. 
Table 3. Risk of Dementiu According to Tertiles of Energy-Adjusted Fat Intake Estimated by Multiple Logistic Reguession: 
The Rotterdam Study 
Alzheimer’s Disease Without 
(n = 37) 
Dementia with a 
(n = 12) 
Cerebrovascular Disease Vascular Component” 
Total Dementia (n = 58) 
- 
n RR (95% CI)b p Trend RR (95% CI)b p Trend RR (95% CI)b p Trend 
Total fat (g/day) 
575.5 1,795 1.0 (ref) 1.0 (ref) 1 .O (ref) 
75.5-8 5.5 1,768 2.1 (0.9-4.7) 1.8 (0.7-4.5) 1.7 (0.3-10.3) 
>85.5 1,823 2.4 (1.1-5.2) 0.02 1.6 (0.6-3.9) 0.25 3.0 (0.6-14.7) 0.02 
529.0 1,873 1.0 (ref) 1.0 (ref) 1.0 (ref) 
29.0-34.0 1,653 1.8 (0.8-4.1) 1.8 (0.74.7) 1.0 (0.1-7.2) 
>34.0 1,860 1.9 (0.9-4.0) 0.12 1.3 (0.5-3.3) 0.66 2.9 (0.6-13.8) 0.01 
5208.5 1,808 1.0 (ref) 1.0 (ref) 1.0 (ref) 
208.5-254.5 1,785 1.1 (0.5-2.4) 1.2 (0.5-3.0) 1.1 (0.34.6) 
>254.5 1,793 1.7 (0.9-3.2) 0.11 1.3 (0.6-3.1) 0.40 0.9 (0.2-3.7) 0.80 
Saturated fat (g/day) 
Cholesterol (mg/day) 
“Includes vascular dementia and Alzheimer’s disease with cerebrovascular disease; other dementias are excluded from these analyses. 
hAdjusted for age, sex, education, and total energy intake. 
RR = relative risk; CI = confidence interval; ref = reference category. 
Table 4. Risk of Dementia According to Tertiles of Energy-Adjusted Linoleic Acid and Fish Intake Estimated by 
Multiple Logistic Regression: The Rotterdam Study 
Alzheimer’s Disease Without 
(n = 37) 
Dementia with a 
(n = 12) 
Cerebrovascular Disease Vascular Component“ 
Total Dementia (n = 58) 
n RR (95% CI)b p Trend RR (95% CI)b p Trend RR (95% CI)b p Trend 
Linoleic acid (giday) 
59.5 1,871 1.0 (ref) 1.0 (ref) 1.0 (ref) 
9.5-15.0 1,775 1.2 (0.7-2.3) 0.9 (0.4-1.9) 1.0 (0.3-3.6) 
>15.0 1,740 0.6 (0.3-1.2) 0.23 0.7 (0.3-1.5) 0.17 0.4 (0.1-1.9) 0.09 
Fish (g/day) 
53.0 1,807 1.0 (ref) 1.0 (ref) 1.0 (ref) 
3.0- 1 8.5 1,773 0.8 (0.4-1.4) 0.9 (0.4-1.8) 0.6 (0.2-2.5) 
>18.5 1,806 0.4 (0.2-0.9) 0.03 0.3 (0.1-0.9) 0.005 0.7 (0.2-2.8) 0.39 
”Includes vascular dementia and Alzheimer’s disease with cerebrovascular disease; other dementias are excluded from these analyses. 
bAdjusted for age, sex, education, and total energy intake. 
h’R = relative risk: CI = confidence interval; ref = reference category. 
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Finally, persons with prevalent cardiovascular disease 
may have altered their diet toward a lower intake of 
saturated fat and cholesterol. Because they might also 
have a higher risk of dementia, this could have resulted 
in an underestimation of our estimates. However, the 
association between saturated fat or cholesterol and de- 
mentia did not change when we excluded subjects with 
cardiovascular disease or subjects using a prescribed 
diet. 
We found a borderline significant association of sat- 
urated fat and cholesterol intake with incident demen- 
tia. This association may have been mediated by car- 
diovascular disease. A high intake of saturated fat and 
cholesterol has been consistently associated with an in- 
creased risk of coronary heart disease 14, 51, and there 
are some data showing an association between dietary 
saturated fat and cerebrovascular disease [6]. Cardiovas- 
cular disease has subsequently been related to demen- 
tia, especially vascular dementia (7-91. The hypothesis 
of a vascular mechanism is consistent with the finding 
that a high saturated fat intake was most strongly re- 
lated to dementia with a vascular component. There- 
fore, we expected that adjustment for cardiovascular 
disease would have attenuated our estimates, but it did 
not. The reason for this may be that we adjusted for 
cardiovascular disease at baseline, whereas it would 
have been optimal to adjust for cardiovascular disease 
that developed during follow-up and before onset of 
dementia. Furthermore, only few subjects suffered 
from clinical stroke [25]. Silent cerebrovascular disease, 
which may be an important intermediate as well, is 
thought to be at least four times more frequent than 
clinically recognized strokes 1291. We had information 
on indicators of atherosclerosis, but only in a relatively 
small subset of subjects, and adjustment for them did 
not change the results either. This may have been due 
to measurement error, lack of power, or the fact that 
these indicators of atherosclerosis might not correlate 
exactly with subclinical lesions of the brain. 
The relation of a high-fat diet to dementia may also 
be related to other factors associated with socioeco- 
nomic status, such as lower education, smoking, and 
alcohol consumption. Adjustment for these factors did 
not change our results, but we cannot exclude residual 
confounding. There may be alternate mechanisms; for 
instance, cholesterol may have a more direct effect on 
the brain. An experimental study in rabbits showed 
that P-amyloid accumulated in a dose-dependent way 
in brains of rabbits fed a high-cholesterol diet [30]. 
In the present study, a high linoleic acid intake was 
slightly, but not significantly, associated with a lower 
risk of dementia. Although some studies have suggested 
that linoleic acid may be atherogenic by increasing the 
oxidative modification of low-density lipoprotein cho- 
lesterol [31], our result is compatible with a beneficial 
effect of linoleic acid on the lipid profile [ 121. 
Fish, as a marker of n-3 PUFAs in fish, was associ- 
ated with a reduced risk of dementia, primarily of AD, 
even at relatively low levels of fish consumption. The 
results of the present study are similar to another 
study, in which we found an inverse association be- 
tween a comparable fish consumption and the risk of 
cognitive impairment and decline [32]. A cross- 
sectional study in Norway indicated that increased 
plasma phospholipid levels of n-3 PUFAs were ob- 
served with a usual intake of one to two servings of fish 
per week [33]. There are several biologically plausible 
mechanisms for the association between fish and AD. 
First, fish may protect against dementia by reducing 
the risk of cardiovascular disease [34, 351. Among sub- 
jects with neuropathologicd brain lesions typical for 
AD, brain infarcts, and especially lacunar infarcts, 
more often resulted in clinical dementia [lo]. In addi- 
tion, results from the Rotterdam Study indicate that 
atherosclerosis is related to an increased risk of AD 191. 
Our finding of a particular association with pure AD 
may suggest a different mechanism as well. The n-3 
PUFAs in fish have antiinflammatory properties; that 
is, they can decrease the production of proinflamma- 
tory cytokines in humans [36]. Immune processes are 
believed to be involved in the pathogenesis of AD. In- 
creased concentrations of acute phase reactants and 
other markers of immune processes, such as cytokines, 
have been found in brain tissue of patients with AD 
1371. In addition, interleukin-1 may regulate the amy- 
loid precursor protein synthesis, resulting in amyloid 
deposits [38]. Epidemiological studies have suggested 
that the use of nonsteroidal antiinflammatory drugs re- 
duced the risk of AD 1391. Finally, n-3 PUFAs also 
play a role in brain development and the functioning 
of nerve membranes [40], and they can still be incor- 
porated in the brains of animals after the period of 
brain development [41]. They may therefore be of im- 
portance in the regeneration of nerve cells [42]. A hu- 
man autopsy study showed that the PUFA content, in- 
cluding the n-3 PUFA docosahexaenoic acid, was 
decreased in the hippocampus and frontal gray matter 
of AD brains, whereas the fatty acid composition of 
normal aged brains was not altered [43]. 
In conclusion, this study suggests that a high satu- 
rated fat and cholesterol intake raises the risk of de- 
mentia, in particular of dementia with a vascular com- 
ponent. In addition, fish consumption may reduce the 
risk of dementia, and primarily of AD. The associa- 
tions we report here are biologically plausible. How- 
ever, because this is the first prospective study examin- 
ing the relation of dietary fat intake to the risk of 
dementia, additional epidemiological studies with a 
longer follow-up period are needed to address this is- 
sue. If these findings are replicated, they could have 
important implications for reducing the risk of demen- 
tia. 
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